CCT245232 是一种有效的热激因子 1 (HSF1) 抑制剂。其中 HSF1 是一种热激反应的主要调节因子，能够诱导多个基因以响应温度升高和其他压力。CCT245232 具有潜力进行增殖性疾病（如癌症）的研究。

HSP90-IN-20 是一种有效的 HSP90抑制剂，IC50为 ≤10 μM。HSP90-IN-20 具有用于癌症研究的潜力。

Flavokawain 1i是chalcones的派生物，包括flavokawain A、flavokawain B和flavokawain C，具有抗癌和抗病毒活性。在30 µM浓度下，Flavokawain 1i能够抑制gefitinib抵抗性的H1975非小细胞肺癌(NSCLC)细胞的增殖率达到36%，同时降低热休克蛋白90(Hsp90)客体蛋白EGFR、c-Met、HER2、Akt和细胞周期依赖性激酶4(Cdk4)的蛋白水平，并提高Hsp70蛋白水平，这是Hsp90抑制的标志。肌肉内给药的Flavokawain 1i能够降低感染猪生殖与呼吸综合征病毒(PRRSV)猪只的病毒滴度。

Hsp90-IN-17 (Example 5) hydrochloride，一种针对增殖性疾病如癌症和神经退行性疾病研究的HSP90抑制剂。

Retaspimycin is a potent and water-soluble Hsp90 inhibitor(EC50s of 119 nM for both Hsp90 and Grp9).

Palmitic acid-13C is intended for use as an internal standard for the quantification of palmitic acid by GC- or LC-MS. Palmitic acid-13C contains 13C at the C2 position and has been used in the study of free fatty acid incorporation into phospholipid fatty acids in soil microbes.1 Palmitic acid is a 16-carbon saturated fatty acid. It comprises approximately 25% of human total plasma lipids.2 It increases protein levels of COX-2 in RAW 264.7 cells when used at a concentration of 75 μM.3 Palmitic acid is involved in the acylation of proteins to anchor membrane-bound proteins to the lipid bilayer.3,4,5,6,7